This is not MJFF-funded work although we are funding Scripps Florida/LoGrasso to work on a LRRK2-related target. We have been in touch with this team and their JNK efforts. Because their program is fully funded by NIH, they didn't need/seek MJFF funds for any of this work.

However, while this general pathway is interesting and may be worthwhile/relevant, I think the claim of "First Known Neuroprotective Compound for Parkinson's" based on rodent data is overstated.

Debi